Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 3, no: 5 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H7K3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 4 |
GO:0006396 | RNA processing | 6 | 4 |
GO:0006397 | mRNA processing | 7 | 4 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 4 |
GO:0006807 | nitrogen compound metabolic process | 2 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0016070 | RNA metabolic process | 5 | 4 |
GO:0016071 | mRNA metabolic process | 6 | 4 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 4 |
GO:0043170 | macromolecule metabolic process | 3 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0046483 | heterocycle metabolic process | 3 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0090304 | nucleic acid metabolic process | 4 | 4 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004651 | polynucleotide 5'-phosphatase activity | 6 | 9 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 9 |
GO:0016791 | phosphatase activity | 5 | 9 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 202 | 206 | PF00656 | 0.686 |
CLV_NRD_NRD_1 | 288 | 290 | PF00675 | 0.520 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 288 | 290 | PF00082 | 0.520 |
CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.537 |
CLV_PCSK_PC1ET2_1 | 122 | 124 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 319 | 321 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.433 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.445 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.569 |
DOC_CKS1_1 | 278 | 283 | PF01111 | 0.645 |
DOC_CYCLIN_yCln2_LP_2 | 154 | 160 | PF00134 | 0.543 |
DOC_CYCLIN_yCln2_LP_2 | 56 | 62 | PF00134 | 0.682 |
DOC_MAPK_gen_1 | 212 | 222 | PF00069 | 0.450 |
DOC_MAPK_gen_1 | 52 | 60 | PF00069 | 0.682 |
DOC_MAPK_MEF2A_6 | 111 | 118 | PF00069 | 0.600 |
DOC_MAPK_MEF2A_6 | 195 | 203 | PF00069 | 0.624 |
DOC_MAPK_MEF2A_6 | 215 | 224 | PF00069 | 0.448 |
DOC_MAPK_MEF2A_6 | 37 | 44 | PF00069 | 0.546 |
DOC_MAPK_MEF2A_6 | 52 | 60 | PF00069 | 0.434 |
DOC_PP2B_LxvP_1 | 352 | 355 | PF13499 | 0.578 |
DOC_PP2B_LxvP_1 | 56 | 59 | PF13499 | 0.693 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.508 |
DOC_USP7_MATH_1 | 325 | 329 | PF00917 | 0.554 |
DOC_WD40_RPTOR_TOS_1 | 303 | 308 | PF00400 | 0.383 |
DOC_WW_Pin1_4 | 259 | 264 | PF00397 | 0.724 |
DOC_WW_Pin1_4 | 277 | 282 | PF00397 | 0.468 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.526 |
LIG_CtBP_PxDLS_1 | 157 | 161 | PF00389 | 0.433 |
LIG_CtBP_PxDLS_1 | 200 | 204 | PF00389 | 0.683 |
LIG_CtBP_PxDLS_1 | 246 | 250 | PF00389 | 0.462 |
LIG_eIF4E_2 | 244 | 250 | PF01652 | 0.614 |
LIG_FHA_1 | 159 | 165 | PF00498 | 0.568 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.511 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.589 |
LIG_FHA_1 | 278 | 284 | PF00498 | 0.615 |
LIG_FHA_1 | 300 | 306 | PF00498 | 0.542 |
LIG_FHA_1 | 331 | 337 | PF00498 | 0.593 |
LIG_FHA_1 | 342 | 348 | PF00498 | 0.503 |
LIG_FHA_2 | 34 | 40 | PF00498 | 0.587 |
LIG_FHA_2 | 354 | 360 | PF00498 | 0.706 |
LIG_GBD_Chelix_1 | 18 | 26 | PF00786 | 0.457 |
LIG_LIR_Apic_2 | 240 | 246 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 366 | 373 | PF02991 | 0.666 |
LIG_LIR_Nem_3 | 366 | 371 | PF02991 | 0.680 |
LIG_Pex14_1 | 318 | 322 | PF04695 | 0.526 |
LIG_SH2_CRK | 128 | 132 | PF00017 | 0.655 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.674 |
LIG_SH2_CRK | 368 | 372 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 368 | 372 | PF00017 | 0.467 |
LIG_SH2_STAT3 | 88 | 91 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 252 | 255 | PF00017 | 0.752 |
LIG_SH2_STAT5 | 330 | 333 | PF00017 | 0.553 |
LIG_SH2_STAT5 | 379 | 382 | PF00017 | 0.564 |
LIG_SH3_3 | 140 | 146 | PF00018 | 0.704 |
LIG_SH3_3 | 220 | 226 | PF00018 | 0.323 |
LIG_SH3_3 | 254 | 260 | PF00018 | 0.656 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.651 |
LIG_SUMO_SIM_anti_2 | 173 | 179 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 156 | 161 | PF11976 | 0.515 |
LIG_SUMO_SIM_par_1 | 198 | 205 | PF11976 | 0.644 |
LIG_SUMO_SIM_par_1 | 57 | 64 | PF11976 | 0.573 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.320 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.620 |
MOD_CK2_1 | 33 | 39 | PF00069 | 0.586 |
MOD_CK2_1 | 353 | 359 | PF00069 | 0.696 |
MOD_Cter_Amidation | 120 | 123 | PF01082 | 0.328 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.432 |
MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.567 |
MOD_GlcNHglycan | 327 | 330 | PF01048 | 0.513 |
MOD_GlcNHglycan | 333 | 336 | PF01048 | 0.554 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.639 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.327 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.418 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.483 |
MOD_GSK3_1 | 264 | 271 | PF00069 | 0.701 |
MOD_GSK3_1 | 273 | 280 | PF00069 | 0.602 |
MOD_GSK3_1 | 293 | 300 | PF00069 | 0.423 |
MOD_GSK3_1 | 325 | 332 | PF00069 | 0.520 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.447 |
MOD_GSK3_1 | 353 | 360 | PF00069 | 0.657 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.605 |
MOD_NEK2_1 | 331 | 336 | PF00069 | 0.543 |
MOD_NEK2_1 | 367 | 372 | PF00069 | 0.687 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.506 |
MOD_NEK2_2 | 348 | 353 | PF00069 | 0.679 |
MOD_PIKK_1 | 230 | 236 | PF00454 | 0.537 |
MOD_PIKK_1 | 295 | 301 | PF00454 | 0.479 |
MOD_PIKK_1 | 80 | 86 | PF00454 | 0.318 |
MOD_PK_1 | 139 | 145 | PF00069 | 0.510 |
MOD_PK_1 | 43 | 49 | PF00069 | 0.567 |
MOD_Plk_1 | 195 | 201 | PF00069 | 0.379 |
MOD_Plk_1 | 348 | 354 | PF00069 | 0.747 |
MOD_Plk_4 | 273 | 279 | PF00069 | 0.583 |
MOD_Plk_4 | 367 | 373 | PF00069 | 0.720 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.567 |
MOD_ProDKin_1 | 259 | 265 | PF00069 | 0.726 |
MOD_ProDKin_1 | 277 | 283 | PF00069 | 0.467 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.518 |
MOD_SUMO_rev_2 | 168 | 173 | PF00179 | 0.454 |
TRG_DiLeu_BaEn_1 | 376 | 381 | PF01217 | 0.521 |
TRG_DiLeu_BaLyEn_6 | 82 | 87 | PF01217 | 0.566 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.646 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.683 |
TRG_ENDOCYTIC_2 | 368 | 371 | PF00928 | 0.475 |
TRG_ER_diArg_1 | 124 | 127 | PF00400 | 0.329 |
TRG_ER_diArg_1 | 216 | 219 | PF00400 | 0.322 |
TRG_NES_CRM1_1 | 12 | 27 | PF08389 | 0.434 |
TRG_Pf-PMV_PEXEL_1 | 24 | 28 | PF00026 | 0.500 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.403 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3D6 | Leptomonas seymouri | 38% | 96% |
A0A1X0NNQ2 | Trypanosomatidae | 25% | 100% |
A0A3Q8ID33 | Leishmania donovani | 79% | 92% |
A0A3R7JXB6 | Trypanosoma rangeli | 26% | 100% |
A4HVY6 | Leishmania infantum | 79% | 92% |
E9APN8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 88% |
Q4QFU1 | Leishmania major | 78% | 100% |